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doi:10.1016/j.kjms.2012.04.026Abstract This study investigated the incidence of retinopathy of prematurity (ROP) and its
risk factors in a tertiary referral hospital in Taiwan to evaluate the applicability of the ROP
screening guidelines published by the American Academy of Pediatrics, American Academy
of Ophthalmology, and American Association for Pediatric Ophthalmology and Strabismus in
2006 (2006 guidelines). A pediatric ophthalmologist applied the 2006 guidelines to screen for
ROP and to treat with laser photocoagulation in each case. We retrieved all records of prema-
ture infants referred for ROP screening at the hospital during 2004 to 2008. Univariate logistic
regression analysis was applied firstly to identify factors correlating with stage 3 ROP or with
laser treatment, and then those significant (p < 0.05) risk factors were analyzed by multivar-
iate logistic regression. In the 138 male and 118 female premature infants in this study, mean
gestation age was 30.8  2.8 weeks, and mean birth weight was 1464.7  434.2 g. The
percentage of infants with ROP in at least one eye was 38.7%. Thirty two (12.5%) had ROP stage
3 or higher in at least one eye. Multivariate logistic regression analysis showed that the best
predictors of type 1 pre-threshold ROP (requiring laser treatment) were young gestational
age, low birth weight and male gender. As medical care of extremely premature infants
improves, timely identification and treatment of conditions such as ROP are essential.1 st Road, Kaohsiung 807, Taiwan.
u.tw (H.-L. Chen).
vier Taiwan LLC. All rights reserved.
602 Y.-H. Lai et al.Although the incidence of ROP in this institute was comparable to that in developing countries
and higher than that in developed countries, the 2006 guidelines originally developed for
a United States population were still applicable. However, the 2006 guidelines should be modi-
fied for a Taiwan population by considering gender.
Copyright ª 2012, Elsevier Taiwan LLC. All rights reserved.Introduction
Retinopathy of prematurity (ROP), a proliferative retinal
vascular disease in premature infants, can cause visual
impairment and even blindness [1,2]. The disease is also
a leading cause of blindness in early childhood [3]. As
survival of premature infants with very low birth weight
improves, the incidence of ROP has increased. In the CRYO-
ROP study, treatment of the threshold disease (at least 5
contiguous or 8 cumulative clock hours of Stage 3 ROP in
zone I or II with plus disease) can decrease the risk of
retinal detachment and blindness [4]. The ROP screening
guidelines published by the American Academy of Pediat-
rics, American Academy of Ophthalmology, and American
Association for Pediatric Ophthalmology and Strabismus in
2006 (2006 guidelines) indicate that, for optimal outcome,
ROP should be treated early (at type 1 pre-threshold ROP)
rather than waiting until development of the threshold
disease [5,6]. The 2006 guidelines recommend initiating
treatment in cases of type 1 pre-threshold ROP (or high risk
pre-threshold ROP), including cases of: (1) any Stage of
ROP in zone I with plus disease; (2) Stage 3 ROP in zone I;
(3) Stage 2 or 3 ROP in zone II with plus disease [5,6].
Hospital/neonatal intensive care unit-specific criteria such
as birth weight (BW) and gestational age (GA) have also
been recommended for ROP screening, especially in
developing countries [5]. The site of this study was a 15-
bed neonatal intensive care unit (NICU) in a southern
Taiwan tertiary referral hospital. The ROP screening
criteria applied at this NICU reflected the 2006 guidelines
with one exception: infants with BW higher than 2000 g
were still referred for ROP screening if they had an
unstable clinical course requiring oxygen therapy. To
obtain the current ROP data needed to establish unit-
specific screening guidelines, this study explored the inci-
dence of ROP, its risk factors, and the applicability of the
2006 guidelines at this facility.
Methods
This retrospective review of records was approved by the
Institutional Review Board of Kaohsiung Medical University
Hospital, Kaohsiung, Taiwan. All premature infants
enrolled were screened by a single pediatric ophthalmol-
ogist (YHL). Data collection included gender, GA, BW, age
of mother, concurrent systemic diseases/conditions, days
on oxygen therapy, worst ROP status, and/or laser treat-
ment. The standard of care in the NICU did not signifi-
cantly change during the study period (years 2004e2008).
In each premature infant, the need for ophthalmologist
consultation was determined by the neonatologists. The
criteria for ophthalmic consultation for the prematureinfants enrolled were any unstable clinical course
requiring high supplemental oxygen. The International
Classification of Retinopathy of Prematurity was used for
ROP staging [7e9]. Laser photocoagulation was performed
by the pediatric ophthalmologist according to indications
for early treatment of ROP specified by the 2003 and 2006
ROP screening guidelines [5,6]. Continuous variables were
presented as means, and standard deviation (SD) and
categorical variables were expressed as numbers and
percentages, respectively. Statistical analyses were per-
formed using SPSS for Windows version 17.0 (SPSS Inc.,
Chicago, IL, USA). Univariate logistic regression analysis
was used to identify risk factors correlating with Stage 3
ROP or with the need for laser treatment. Significant
(p< 0.05) risk factors were then analyzed by multivariate
logistic regression.
Results
Of the 261 premature infants screened by the pediatric
ophthalmologist, five were excluded due to incomplete
medical records (one without GA data, three without
systemic data, and one without initial retinal examination
data). The analysis therefore included 256 (98.1%) of the
261 premature infants screened.
Demographic data
In the 256 infants enrolled (138 male, 118 female), average
GA was 30.8 2.8 weeks (95% CI, 30.5e31.2 weeks; range
24.3e38.1 weeks). The GA was  28 weeks in 49 (19.1%; 95%
CI, 14.3e24.0%) and  30 weeks in 100 (39.1%; 95% CI,
33.1e45.1%). Mean BW was 1464.7 434.2 g (95% CI,
1411.3e1518.2 g; range 541e3250 g). About half (53.1%) of
the infants were  1500 g (95% CI, 47.0e59.3%), and 233
(91.0%) were  2000 g (95% CI, 87.5e94.5%). Singleton,
twins and triplets comprised 71.4%, 25.9% and 1.2%,
respectively. More than half (56.4%) were outborn (95% CI,
50.0e62.8%). Table 1 shows the GA and BW data for infants
in different stages of ROP and for those who required laser
treatment. Three infants died of respiratory failure. One
infant (male, GAZ 26.1 weeks, BWZ 940 g) had sepsis
shock, pneumonia, intraventricular hemorrhage (IVH),
respiratory distress syndrome (RDS), and chronic lung
diseases; another infant (male, GAZ 25.3 weeks, and
BWZ 670 g) had pneumonia, disseminated intravascular
coagulation (DIC), necrotizing enterocolitis, IVH, hydro-
cephalus, and RDS. Both of these infants, however, showed
regression of ROP after laser photocoagulation. The third
infant (female, GAZ 33.4 weeks, and BWZ 1940 g), who
did not have ROP, died of heart failure, renal failure, DIC,
ascites, pneumonia, fungiemia, and sepsis shock.
Table 1 Distribution of gestational age and birth weight according to retinopathy of prematurity stage and laser treatment.
n (% of total) Number ROP Stage 1 ROP Stage 2 ROP Stage 3 ROPa All Laser
GA
 28 weeks 8 (16.3) 6 (12.2) 13 (26.5) 22 (44.9) 49 (100.0) 14 (28.6)
29e30 weeks 27 (52.9) 17 (33.3) 11 (21.6) 6 (11.8) 51 (100.0) 3 (5.9)
> 30 weeks 122 (78.2) 43 (27.6) 25 (16.0) 4b (2.6) 156 (100.0) 0
Total 157 (61.3) 42 (16.4) 25 (9.8) 32 (12.5) 256 (100.0) 17 (6.6)
Mean GA (SD) 31.9 (2.2) 30.6 (2.2) 28.3 (3.7) 27.6 (2.3) 30.8 (2.8) 26.5 (1.3)
BW
 1000 g 8 (19.5) 5 (12.2) 10 (24.4) 18 (43.9) 41 (100.0) 12 (29.3)
1001e1500 g 51 (53.7) 21 (22.1) 10 (10.5) 13 (13.7) 95 (100.0) 5c (5.3)
1501e2000 g 75 (77.3) 16 (16.5) 5 (5.2) 1 (1.0)d 97 (100.0) 0
> 2000 g 23 (100.0) 0 0 0 23 (100.0) 0
Total 157 (61.3) 42 (16.4) 25 (9.8) 32 (12.5) 256 (100.0) 17 (6.6)
Mean BW (SD) 1629.0 (403.3) 1368.9 (321.9) 1185.1 (360.4) 1002.9 (250.7) 1464.7 (434.2) 886.2 (145.5)
BWZ birth weight; GAZ gestational age; ROPZ retinopathy of prematurity; SDZ standard deviation.
a All ROP stages were 1e3.
b All GAs< 35 weeks.
c All BWs< 1251 g.
d BWZ 1620 g.
Retinopathy of prematurity screening criteria 603Stage 3 ROP or worse
The percentage of infants with ROP in at least one eye was
38.7% (95% CI, 32.7e44.7%). Thirty-two (12.5%) had ROP
Stage 3 or higher in at least one eye (95% CI, 8.4e16.6%).
Stage 3 was noted in the right and left eyes of 10.2% (95%
CI, 6.4e13.9%) and 11.3% (95% CI, 7.4e15.2%), which was
not a significant difference. The 32 infants in Stage 3 had
a mean GA of 27.6 ( 2.3) weeks and a mean BW of 1002.9
( 250.7) g. The male-to-female ratio was 1.9 (21:11). Of
the infants with Stage 3 ROP, all except one weighed 
1500 g (1620 g). In infants with BW  1000 g, BW
1001e1500 g, and BW 1501e2000 g, 41.5% (nZ 17), 13.7%
(nZ 13), and 1.0% (nZ 1) had Stage 3 ROP, respectively. In
all 32 infants with Stage 3 ROP, BW was  2000 g, and GA
was < 35 weeks. Four of the infants with Stage 3 ROP had
GA > 30 weeks (30.7 weeks, 30.9 weeks, 34.1 weeks, and
34.3 weeks). No infants had Stage 4 ROP or worse.
Laser photocoagulation
Seventeen infants required laser photocoagulation in both
eyes (6.6%; 95% CI, 3.6e9.7%), and all were < 1500 g. Mean
GA was 26.5 ( 1.3) weeks, and mean BW was 886.2
( 145.5) g. The male-to-female ratio was 4.7 (14:3). In all
seventeen patients, ROP regressed after laser photocoag-
ulation, and no adverse events occurred. Only half of the
Stage 3 ROP patients (16 of the 32) required laser treat-
ment, while one patient without Stage 3 ROP fulfilled the
treatment indication. Of 41 infants with BW  1000 g,
twelve (29.3%) had received laser treatment. Of 95 with BW
of 1001e1500 g, five (5.3%) had received laser treatment
(BWsZ 1020 g, 1060 g, 1090 g, 1100 g, and 1114 g, respec-
tively). In all patients who had received laser treatment,
GA was  30 weeks. Of the twenty-nine with GA  28
weeks, 14 (28.6%) had received laser treatment. Of the 51
infants with GA 29e30 weeks, three (5.9%) had received
laser treatment. Table 1 shows other relevant data.Logistic analysis
Univariate logistic analysis showed that GA, BW, patent
ductus arteriosus (PDA), anemia, IVH, and days on oxygen
therapy were associated with Stage 3 ROP (Table 2).
However, multivariate logistic analysis by the stepwise
(likelihood ratio) method showed that only GA was signifi-
cantly associated with Stage 3 ROP. Univariate logistic
analysis showed that GA, BW, PDA, anemia, IVH, and days
on oxygen therapy were associated with the need for laser
treatment (Table 3). Multivariate logistic analysis by the
stepwise (likelihood ratio) method showed that GA, BW,
and male gender (a positive risk factor) were significantly
associated with the need for laser therapy. Tables 2and 3
show the detailed data related to characteristics of
patients’ systemic diseases/conditions and ages of the
mother that were associated with Stage 3 ROP or with the
need for laser treatment. Table 4 shows that mean GA was
0.7 weeks younger in males than in females. Table 4 shows
other data regarding gender analysis.Discussion
Table 1 shows that the 2006 guidelines are suitable for
screening neonates at this institution. All infants who
needed laser treatment weighed 2000 g or less. Although
four (2.6%) infants with GA > 30 weeks had Stage 3 ROP,
none met the criteria for laser treatment. The incidence
of ROP in this institute was comparable to that in Saudi
Arabia (61.4% for GA 29e32 weeks) and in Turkey (49.4%
for BW < 1250 g) [10,11] but was higher than that in
Sweden (55.6% for GA Z 26 weeks) and in USA (7.75% for
GA 29e30 weeks) [12,13]. Further study of ROP morbidity
in the 49 infants with GA  28 weeks showed that 41
(83.7%) had ROP. Of these, 22 (53.7%) had Stage 3 ROP, and
14 (34.1%) required laser treatment. In the 41 infants with
BW  1000 g, 33 (80.5%) had ROP. Of these, 18 (54.5%) had
Table 2 Logistic regression analysis of premature infants in association with Stage 3 ROP.
Stage 3 or
worse
Stage 2 or
bettera
OR (95% CI) p Adjusted ORb p
Gender
Female 10 108 0.516 (0.232e1.145) 0.104
Male 21 117 Reference
GA (w) 27.6 2.4 31.3 2.5 0.551 (0.452e0.673) < 0.001 0.555 (0.449e0.686) < 0.001
BW (g) 1017.8 240.0 1526.3 418.9 0.996 (0.995e0.997) < 0.001 d > 0.05
Outborn
Yes 11 121 0.489 (0.216e1.105) 0.085
No 16 86 Reference
PDA
Yes 25 102 4.739 (1.870e12.009) 0.001 d > 0.05
No 6 116 Reference
Heart diseasec
Yes 3 35 0.560 (0.161e1.944) 0.361
No 28 183 Reference
RDS
Yes 30 171 283416648 (0.000e.) 0.997
No 0 48 Reference
Infectiond
Yes 18 139 0.853 (0.390e1.861) 0.689
No 12 79 Reference
Hyperbilirubinemia
Yes 28 185 2.497 (0.568e10.988) 0.226
No 2 33 Reference
Anemia
Yes 27 113 6.272 (2.123e18.528) 0.001 d > 0.05
No 4 105 Reference
IVH
Yes 12 35 3.302 (1.472e7.409) 0.004 d > 0.05
No 19 183 Reference
Apnea
Yes 20 108 1.852 (0.847e4.049) 0.123
No 11 110 Reference
Days on oxygen 56.1 44.8 19.0 25.9 1.028 (1.016e1.040) < 0.001 d > 0.05
Weight gaine (g) 297.5 338.4 455.2 645.4 0.999 (0.998e1.000) 0.164
Age of mother (y) 30.0 4.1 30.9 5.1 0.964 (0.891e1.042) 0.356
BWZ birth weight; GAZ gestational age at birth; IVHZ intraventricular hemorrhage; ORZ odds ratio; PDAZ patent ductus arteriosus;
RDSZ respiratory distress syndrome; ROPZ retinopathy of prematurity.
a Including infants without ROP.
b Adjusted odds ratios were calculated by both forward stepwise (likelihood ratio) and backward stepwise (likelihood ratio) methods.
c Excluding PDA.
d Including sepsis.
e Weight gain at first examination.
604 Y.-H. Lai et al.Stage 3 ROP, and 12 (36.4%) required laser treatment. A
significant portion of the infants (GA 28 weeks or
BW 1000 g) developed severe ROP requiring laser
treatment.
Multivariate logistic regression analysis showed that GA
was the only significant predictor for Stage 3 ROP. Although
many studies have confirmed that both GA and BW are risk
factors for ROP, none have analyzed risk factors for severe
ROP [14]. Not all patients with ROP develop type 1 pre-
threshold ROP, which requires laser treatment. The
finding that GA was a stronger predictor compared to BW is
reasonable as data for infants at a young GA may interfere
with the statistical results.The average GA was significantly younger (by about 4.9
days) in the male infants than in the female infants in this
study. However, systemic disease was not gender-related.
Interestingly, multivariate logistic regression analysis
showed that male gender was a risk factor for type 1 pre-
threshold ROP, which requires laser treatment, but not for
Stage 3 ROP. In twin pregnancy, male gender in one or both
twins is a risk factor for preterm delivery [15]. Systemic
morbidity is also reportedly more common in infant males
[16]. Both this and the above studies agree that premature
males are susceptible to ROP and systemic morbidity.
However, further studies are needed to clarify the precise
mechanism of this susceptibility.
Table 3 Logistic regression analysis of premature infants in terms of laser treatment for retinopathy of prematurity
Laser No lasera OR (95% CI) p Adjusted ORb p
Gender
Female 3 115 0.231 (0.065e0.825) 0.024 0.111 (0.019e0.667) 0.016
Male 14 124 Reference
GA (w) 26.5 1.3 31.1 2.6 0.404 (0.279e0.586) < 0.001 0.579 (0.343e0.979) 0.042
BW (g) 886.2 145.5 1505.9 418.3 0.994 (0.991e0.996) < 0.001 0.996 (0.992e1.000) 0.039
Outborn
Yes 7 125 0.896 (0.292e2.753) 0.848
No 6 96 Reference
PDA
Yes 13 114 3.364 (1.065e10.622) 0.039 d > 0.05
No 4 118 Reference
Heart diseasec
Yes 2 36 0.726 (0.159e3.311) 0.679
No 15 196 Reference
RDS
Yes 17 184 149255796 (0.000e.) 0.997
No 0 48 Reference
Infectiond
Yes 10 147 0.816 (0.300e2.224) 0.692
No 7 84 Reference
Hyperbilirubinemia
Yes 15 198 1.250 (0.273e5.719) 0.774
No 2 33 Reference
Anemia
Yes 15 125 6.420 (1.436e28.710) 0.015 d > 0.05
No 2 107 Reference
IVH
Yes 7 40 3.360 (1.207e9.357) 0.020 d > 0.05
No 10 192 Reference
Apnea
Yes 10 118 1.380 (0.508e3.750) 0.528
No 7 114 Reference
Days on oxygen 77.8 45.8 19.8 26.3 1.035 (1.020e1.051) < 0.001 d > 0.05
Weight gaine (g) 352.1 393.1 442.6 631.8 1.000 (0.998e1.001) 0.580
Age of mother (y) 30.2 3.5 30.8 5.1 0.976 (0.876e1.087) 0.660
BWZ birth weight; GAZ gestational age at birth; IVHZ intraventricular hemorrhage; ORZ odds ratio; PDAZ patent ductus arterio-
sus; RDSZ respiratory distress syndrome; ROPZ retinopathy of prematurity.
a Including infants without ROP.
b Adjusted odds ratios were calculated by both forward stepwise (likelihood ratio) and backward stepwise (likelihood ratio) methods.
c Excluding PDA.
d Including sepsis.
e Weight gain at first examination.
Retinopathy of prematurity screening criteria 605Although poor post-natal weight gain is reportedly a risk
factor for severe ROP [17], the current study revealed no
significant correlation. As infants with severe ROP tended
to have low body weight and relatively worse clinical
conditions, BW may have confounded post-natal weight
gain. Whereas older maternal age is another reported risk
factor for ROP [18], the current study again revealed no
correlation. Unlike the studies cited above, this study
analyzed relatively more severe stages of ROP (Stage 3 ROP
and type 1 pre-threshold ROP). The results of this study
suggest that maternal age may be related to ROP but not to
severe ROP. Another possibility is that the age of the
mother correlates positively with premature birth, i.e.,
premature birth is more common in older mothers than in
younger mothers [19].In conclusion, the 2006 guidelines are suitable for
screening premature infants for ROP at this neonatal
intensive care unit. The recommended screening criteria in
this institute were any infants with GA < 31 weeks or BW
 1500 g, or selected infants with BW of 1500e2000 g or GA
> 30 weeks with an unstable clinical course. In this pop-
ulation, low BW, young GA, and male gender are risk factors
for laser treatment. As advances in pediatric care improve
survival in extremely premature infants and as treatment
for the most advanced stages of ROP require an increasingly
specialized workforce and precision instruments, NICUs in
this and other hospitals must prepare to manage growing
numbers of premature infants with severe and complicated
ROP. Therefore, in addition to recruiting and training
qualified personnel for managing complicated ROP,
Table 4 Gender differences in clinical characteristics of
premature infants.
Male Female p
Laser
Yes 14 3 0.015
No 124 115
 Stage 3 ROP
Yes 21 10 0.099
No 117 108
GA (weeks) 30.5 2.8 31.2 2.6 0.031
BW (g) 1468.1 461.0 1460.8 402.6 0.893
PDA
Yes 65 62 0.471
No 68 54
Heart diseasesa
Yes 17 21 0.244
No 117 95
RDS
Yes 107 94 0.886
No 25 23
Any infectionb
Yes 83 74 0.882
No 49 42
Anemia
Yes 74 66 0.842
No 59 50
IVH
Yes 27 20 0.538
No 106 96
Apnea
Yes 73 55 0.239
No 60 61
Outborn
Yes 69 63 0.962
No 53 49
BWZ birth body weight; GAZ gestational age at birth;
IVH Z intraventricular hemorrhage; PDAZ patent ductus arte-
riosus; RDSZ respiratory distress syndrome; ROPZ retinopathy
of prematurity.
a Excluding PDA.
b Including sepsis.
606 Y.-H. Lai et al.hospitals must prepare by acquiring the facilities and
equipment needed for treating this condition.References
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